- Home
- NDRA vs ATCH Comparison
NDRA vs ATCH Comparison
Compare NDRA & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- ATCH
- Stock Information
- Founded
- NDRA 2007
- ATCH 2022
- Country
- NDRA United States
- ATCH United States
- Employees
- NDRA N/A
- ATCH N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATCH
- Sector
- NDRA Health Care
- ATCH
- Exchange
- NDRA Nasdaq
- ATCH Nasdaq
- Market Cap
- NDRA 3.1M
- ATCH 2.9M
- IPO Year
- NDRA 2017
- ATCH N/A
- Fundamental
- Price
- NDRA $4.71
- ATCH $1.62
- Analyst Decision
- NDRA Strong Buy
- ATCH
- Analyst Count
- NDRA 1
- ATCH 0
- Target Price
- NDRA $46.00
- ATCH N/A
- AVG Volume (30 Days)
- NDRA 30.1K
- ATCH 57.7M
- Earning Date
- NDRA 11-14-2025
- ATCH 11-14-2025
- Dividend Yield
- NDRA N/A
- ATCH N/A
- EPS Growth
- NDRA N/A
- ATCH N/A
- EPS
- NDRA N/A
- ATCH N/A
- Revenue
- NDRA N/A
- ATCH $14,825,966.00
- Revenue This Year
- NDRA N/A
- ATCH N/A
- Revenue Next Year
- NDRA N/A
- ATCH N/A
- P/E Ratio
- NDRA N/A
- ATCH N/A
- Revenue Growth
- NDRA N/A
- ATCH 1066.77
- 52 Week Low
- NDRA $2.90
- ATCH $0.14
- 52 Week High
- NDRA $22.68
- ATCH $26.94
- Technical
- Relative Strength Index (RSI)
- NDRA 52.93
- ATCH 89.12
- Support Level
- NDRA $4.00
- ATCH $0.17
- Resistance Level
- NDRA $5.28
- ATCH $1.18
- Average True Range (ATR)
- NDRA 0.34
- ATCH 0.15
- MACD
- NDRA 0.11
- ATCH 0.13
- Stochastic Oscillator
- NDRA 55.47
- ATCH 87.91
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.